fly like an eagle schreef op 21 maart 2014 14:07:
The global healthcare industry is seeing new developments, improved point-of-care diagnostics, cost-effective treatment modalities, and advances in personalized medicine, which not only offer efficient early diagnosis, but also allow for the treatment of cancer conditions in order to reduce the healthcare cost and disease burden. Cancer/tumor profiling is one such technology with the potential to revolutionize cancer diagnostics and therapeutics in the healthcare industry. These applications offer tremendous opportunities for key players in this market.
BCC Research provides an in-depth analysis of the global market for cancer profiling technologies through its report Cancer Profiling and Pathways: Technologies and Global Markets. According to the report, this market was valued at more than $26.1 billion in 2012 and $30 billion in 2013. BCC Research projects the market to grow to nearly $54.8 billion by 2018, and register a five-year compound annual growth rate of 12.8% from 2013 to 2018.